💊💉 #ibrutinib
SmPC for IMBRUVICA 560 mg film-coated tablets has been updated with changes to sections 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 6.5 Nature and contents of container; 10. Date of revision of the text on 03 April 2023.
🌐 https://www.medicines.org.uk/emc/product/10041/smpc
Change log: https://www.medicines.org.uk/emc/product/10041/smpc/history

💊💉 #ibrutinib
SmPC for IMBRUVICA 420 mg film-coated tablets has been updated with changes to sections 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 6.5 Nature and contents of container; 10. Date of revision of the text on 03 April 2023.
🌐 https://www.medicines.org.uk/emc/product/10040/smpc
Change log: https://www.medicines.org.uk/emc/product/10040/smpc/history

💊💉 #ibrutinib
SmPC for IMBRUVICA 280 mg film-coated tablets has been updated with changes to sections 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 6.5 Nature and contents of container; 10. Date of revision of the text on 03 April 2023.
🌐 https://www.medicines.org.uk/emc/product/10039/smpc
Change log: https://www.medicines.org.uk/emc/product/10039/smpc/history

💊💉 #ibrutinib
SmPC for IMBRUVICA 140 mg film-coated tablets has been updated with changes to sections 4.8 Undesirable effects; 5.1 Pharmacodynamic properties; 6.5 Nature and contents of container; 10. Date of revision of the text on 03 April 2023.
🌐 https://www.medicines.org.uk/emc/product/10025/smpc
Change log: https://www.medicines.org.uk/emc/product/10025/smpc/history

RT @Med_Digest_org@twitter.com

Prof. Saskia Middeldorp about important trials which were published on #LMWH use in #pregnancy at #ASH22. -> http://bit.ly/3Qsa2Zs
@MiddeldorpS@twitter.com @Radboudumc@twitter.com @ASH_hematology@twitter.com
#Highlow trial #LMWH in pregnant women with previous #VTE
#ALPINE trial #ibrutinib vs #zanubrutinib in CLL

🐦🔗: https://twitter.com/Med_Digest_org/status/1613585584366419969